Previous Page  16 / 26 Next Page
Information
Show Menu
Previous Page 16 / 26 Next Page
Page Background

Page 43

Notes:

allied

academies

J Pharmacol Ther Res 2017 Volume 1 Issue 2

November 02-03, 2017 Chicago, USA

4

th

International Congress on

International Conference and Exhibition on

Drug Discovery, Designing and Development

Biochemistry, Molecular Biology: R&D

&

The study on the effect of non-enzymatic glycation on the interaction of human serum albumin and

sodium-fluorescein, via spectroscopic analyses

Priyankar Sen, Sadaf Fatima, Tamanna Anwar, Nabeel Ahmad

and

Asimul Islam

VIT University, India

T

he binding of SF to Human Serum Albumin (HSA) has

been predicted by molecular docking and investigated by

circular dichroism (CD) and fluorescence spectroscopy with

or without glycation at temperatures 296K, 301K, and 310K.

The binding parameters were calculated by quenching of

emission spectrum of a constant concentration of SF (2 μM)

at 513 nm against increasing concentrations of glycated or

unmodified HSA as quencher starting from stochiometry ratio

of 1:1. Sodium Fluorescein (SF) is a fluorescent tracer dye used

extensively in diagnostic tools in the field of Ophthalmology,

particularly in intravenous fluorescein angiography (IVFA). The

HSA-SF interaction found to be a static binding. The Stern-

Volmer constants (Ksv) were in the range of ~104 M-1 and

other thermodynamic parameters like enthalpy (ΔH0), free

energy (ΔG0) and entropy (ΔS0) are like albumin ligand bindings

reported by previous workers. The interactions were found

to be spontaneous, irrespective of temperature or glycation.

Glycated HSA is clinically used to monitor unstable glycemic

controls in diabetic patients. 39% increase in binding affinity

(log K) and free energy (ΔG0) is reported on glycation at 310 K

(room temperature), which may be important in the SF based

angiographies. Further, on glycation HSA-SF binding seems to

change from an enthalpy-driven to an entropy-driven reaction.

SF shows best binding to FA binding site III of HSA, which also

overlaps with drug binding site II of sub domain IIIA. Leu-430

seems to play a pivotal role in the interaction. This is the first

report of glycated HSA and SF binding and comparison between

the thermodynamic parameters of the bindings in the absence

and presence of glycation at different temperatures.

Speaker Biography

Priyankar Sen is working in the field of protein folding and protein ligand interactions

for the enhanced understanding of the molecular behavior of proteins, specifically

albumins. He has done his PhD from Rizwan Khan’s Lab in IBU, Aligarh Muslim

University, India and Post-doctorate from Salunke’s Lab, NII, New Delhi. Out of 5 years’

Doctoral and 8 years Post-doctoral research, he has published 21 papers in international

peer reviewed journals. He is currently working as Assistant Professor in VIT University.

Currently, he is focusing on expression and modification of therapeutically important

proteins and further scale up in bioreactors.

e:

priyankar.sen@vit.ac.in